Skip to main content

Table 5 KEGG pathway enrichment analysis of the potential genes of HCP5

From: LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis

KEGG ID

Term

Count

P value

Genes

hsa04145

Phagosome

18

9.74E−15

HLA-DRB5, NCF2, HLA-B, TAP2, TAP1, HLA-A, HLA-F, HLA-G, CTSS, HLA-DMA, HLA-DPB1, HLA-DRA, HLA-DOA, HLA-DQA1, HLA-DRB1, HLA-DPA1, HLA-DQB1, HLA-E

hsa04514

Cell adhesion molecules (CAMs)

16

1.31E−12

CD274, HLA-DRB5, HLA-B, HLA-A, HLA-F, HLA-G, HLA-E, HLA-DMA, HLA-DPB1, HLA-DRA, CD58, HLA-DOA, HLA-DQA1, HLA-DRB1, HLA-DPA1, HLA-DQB1

hsa04668

TNF signaling pathway

8

4.89E−05

MLKL, IL15, CASP10, CCL5, TNFAIP3,CFLAR, TNFRSF1B, BIRC3

hsa04064

NF-kappa B signaling pathway

6

0.001138

DDX58, PLCG2, TNFAIP3, CFLAR,TNFSF13B, BIRC3

hsa05203

Viral carcinogenesis

8

0.002532

SP100, IRF7, HLA-B, HLA-A, HLA-F,HLA-G, IRF9, HLA-E

hsa04210

Apoptosis

4

0.018872

CASP10, TNFSF10, CFLAR, BIRC3

hsa04144

Endocytosis

7

0.022316

HLA-B, ARAP2, HLA-A, HLA-F, HLA-G,CYTH1, HLA-E

  1. KEGG Kyoto Encyclopedia of Genes and Genomes